Shares of GNC Holdings Inc (NYSE:GNC) have been assigned an average rating of “Hold” from the six ratings firms that are currently covering the company, Marketbeat reports. Two analysts have rated the stock with a sell rating, three have given a hold rating and one has issued a buy rating on the company. The average 12-month target price among brokers that have issued a report on the stock in the last year is $3.13.

A number of analysts recently commented on the company. ValuEngine raised Zynerba Pharmaceuticals from a “hold” rating to a “buy” rating in a research report on Friday, May 17th. Zacks Investment Research raised Hudson Technologies from a “sell” rating to a “hold” rating in a research report on Wednesday, May 29th. Finally, Jefferies Financial Group decreased their target price on Huntsman from $33.00 to $30.00 and set a “buy” rating for the company in a research report on Monday, June 17th.

GNC stock traded up $0.01 during midday trading on Monday, reaching $1.88. The stock had a trading volume of 2,135,133 shares, compared to its average volume of 1,723,550. GNC has a 12 month low of $1.32 and a 12 month high of $4.65. The company has a market cap of $157.02 million, a P/E ratio of 5.53 and a beta of 1.21. The business has a fifty day moving average price of $1.54.

GNC (NYSE:GNC) last issued its earnings results on Monday, July 22nd. The specialty retailer reported $0.13 EPS for the quarter, beating analysts’ consensus estimates of $0.07 by $0.06. GNC had a negative return on equity of 17.50% and a net margin of 2.09%. The business had revenue of $534.00 million during the quarter, compared to analyst estimates of $553.30 million. During the same period in the previous year, the company posted $0.20 EPS. The firm’s revenue was down 13.6% compared to the same quarter last year. Sell-side analysts predict that GNC will post 0.39 earnings per share for the current fiscal year.

A number of hedge funds have recently added to or reduced their stakes in the business. FMR LLC boosted its stake in GNC by 0.4% during the 1st quarter. FMR LLC now owns 7,912,006 shares of the specialty retailer’s stock valued at $21,600,000 after purchasing an additional 35,000 shares during the last quarter. Alpha Omega Wealth Management LLC boosted its stake in GNC by 183.0% during the 1st quarter. Alpha Omega Wealth Management LLC now owns 10,052 shares of the specialty retailer’s stock valued at $27,000 after purchasing an additional 6,500 shares during the last quarter. FNY Investment Advisers LLC boosted its stake in GNC by 9,900.0% during the 1st quarter. FNY Investment Advisers LLC now owns 25,000 shares of the specialty retailer’s stock valued at $68,000 after purchasing an additional 24,750 shares during the last quarter. Norges Bank acquired a new position in GNC during the 4th quarter valued at about $1,126,000. Finally, Macquarie Group Ltd. boosted its stake in GNC by 449.1% during the 4th quarter. Macquarie Group Ltd. now owns 30,200 shares of the specialty retailer’s stock valued at $72,000 after purchasing an additional 24,700 shares during the last quarter. Institutional investors and hedge funds own 52.82% of the company’s stock.

About GNC

GNC Holdings, Inc, together with its subsidiaries, operates as a specialty retailer of health, wellness, and performance products. The company operates through three segments: U.S. and Canada, International, and Manufacturing/Wholesale. Its products include proteins, performance supplements, weight management supplements, vitamins, herbs and greens, wellness supplements, health and beauty products, food and drink products, and other general merchandise.

Read More: How interest rates affect municipal bond prices

Receive News & Ratings for GNC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GNC and related companies with MarketBeat.com's FREE daily email newsletter.